Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 118 entries
View as:

Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users

Phase: N/A Priority: Normal
NCT ID: NCT03657355 Org: User:
Start: 09/07/18 End: 08/08/19 Due: 08/08/20

The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT04252495 Org: User:
Start: 06/26/20 End: 05/06/21 Due: 05/06/22

A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

Phase: N/A Priority: Normal
NCT ID: NCT03657446 Org: User:
Start: 09/18/18 End: 10/26/18 Due: 10/26/19

A Study to Examine the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-777991 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04798209 Org: User:
Start: 01/29/21 End: 05/21/22 Due: 05/21/23

To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

Phase: N/A Priority: Normal
NCT ID: NCT04281342 Org: User:
Start: 01/14/20 End: 09/03/21 Due: 09/03/22

A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

Phase: N/A Priority: Normal
NCT ID: NCT05597020 Org: User:
Start: 02/16/23 End: 04/18/24 Due: 04/18/25

Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04753164 Org: User:
Start: 02/16/21 End: 03/25/22 Due: 03/25/23

Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping

Phase: N/A Priority: Normal
NCT ID: NCT00558311 Org: User:
Start: 12/14/07 End: 07/13/10 Due: 07/13/11

A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease

Phase: N/A Priority: Normal
NCT ID: NCT03737214 Org: User:
Start: 12/18/18 End: 11/30/29 Due: 11/30/30

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod

Phase: N/A Priority: Normal
NCT ID: NCT04819464 Org: User:
Start: 08/25/21 End: 08/18/24 Due: 08/18/25

A Clinical Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03799978 Org: User:
Start: 03/09/19 End: 03/18/19 Due: 03/18/20

A Study to Assess the Tolerability, Safety, Pharmacodynamics, and Pharmacokinetics of Ascending Single Doses (Including Food Interaction) and Ascending Multiple Doses of ACT-453859, and Multiple Doses of Setipiprant (ACT-129968)

Phase: N/A Priority: Normal
NCT ID: NCT02381496 Org: User:
Start: 12/31/11 End: 04/30/12 Due: 04/30/13

To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.

Phase: N/A Priority: Normal
NCT ID: NCT04255277 Org: User:
Start: 01/31/20 End: 10/18/21 Due: 10/18/22

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01877629 Org: User:
Start: 07/01/11 End: 07/01/11 Due: 07/01/12

A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03372629 Org: User:
Start: 01/12/18 End: 12/02/18 Due: 12/02/19

Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT02560532 Org: User:
Start: 03/01/16 End: 05/02/17 Due: 05/02/18

Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2

Phase: N/A Priority: Normal
NCT ID: NCT04470713 Org: User:
Start: 07/31/19 End: 10/30/21 Due: 10/30/22

A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Dabigatran and Rosuvastatin in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05480475 Org: User:
Start: 09/03/22 End: 09/17/22 Due: 09/17/23

A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03814200 Org: User:
Start: 01/03/19 End: 02/19/19 Due: 02/19/20

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05648500 Org: User:
Start: 12/13/22 End: 05/01/27 Due: 05/01/28

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT05672576 Org: User:
Start: 06/26/23 End: 05/01/27 Due: 05/01/28

A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented

Phase: N/A Priority: Normal
NCT ID: NCT05702177 Org: User:
Start: 01/05/23 End: 04/25/23 Due: 04/25/24

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Phase: N/A Priority: Normal
NCT ID: NCT03575104 Org: User:
Start: 05/29/18 End: 05/14/20 Due: 05/14/21

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT02472795 Org: User:
Start: 06/01/15 End: 02/28/17 Due: 02/28/18

A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04557280 Org: User:
Start: 11/06/20 End: 12/19/20 Due: 12/19/21